Fisher & Paykel Healthcare's Progress Attracts New Bull -- Market Talk

Dow Jones

05/29

2226 GMT [Dow Jones]--Fisher & Paykel Healthcare gets a new bull in Jefferies following its FY 2025 result that showed growth across key divisions. Annual revenue rose by 16% on a year ago, with new app consumables up 20% and masks for treating sleep apnea up 14%. Gross margin expanded by 181 basis points. "With lead share, ongoing gains through clinical practice, further operating leverage and, as we see it, better placed with regard to tariffs, we move to Buy (from Hold)," says analyst Vanessa Thomson. Fisher & Paykel Healthcare is up 0.2% in early trading at NZ$35.07. (david.winning@wsj.com)

(END) Dow Jones Newswires

May 28, 2025 18:28 ET (22:28 GMT)

应版权方要求，你需要登录查看该内容

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2539111402"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2539111402\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2539111402?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-05-29 06:28","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2539111402","market":"hk","top_or_hot":-1,"title":"Fisher & Paykel Healthcare's Progress Attracts New Bull -- Market Talk","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<pre>\n \n</pre>\n<p>\n  2226 GMT [Dow Jones]--Fisher &amp; Paykel Healthcare gets a new bull in Jefferies following its FY 2025 result that showed growth across key divisions. Annual revenue rose by 16% on a year ago, with new app consumables up 20% and masks for treating sleep apnea up 14%. Gross margin expanded by 181 basis points. \"With lead share, ongoing gains through clinical practice, further operating leverage and, as we see it, better placed with regard to tariffs, we move to Buy (from Hold),\" says analyst Vanessa Thomson. Fisher &amp; Paykel Healthcare is up 0.2% in early trading at NZ$35.07. (david.winning@wsj.com) \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  May 28, 2025 18:28 ET (22:28 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Fisher & Paykel Healthcare's Progress Attracts New Bull -- Market Talk</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nFisher & Paykel Healthcare's Progress Attracts New Bull -- Market Talk\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2025-05-29 06:28</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<pre>\n \n</pre>\n<p>\n  2226 GMT [Dow Jones]--Fisher &amp; Paykel Healthcare gets a new bull in Jefferies following its FY 2025 result that showed growth across key divisions. Annual revenue rose by 16% on a year ago, with new app consumables up 20% and masks for treating sleep apnea up 14%. Gross margin expanded by 181 basis points. \"With lead share, ongoing gains through clinical practice, further operating leverage and, as we see it, better placed with regard to tariffs, we move to Buy (from Hold),\" says analyst Vanessa Thomson. Fisher &amp; Paykel Healthcare is up 0.2% in early trading at NZ$35.07. (david.winning@wsj.com) \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  May 28, 2025 18:28 ET (22:28 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"FPH.NZ","symbol_name":"Fisher & Paykel Healthcare Corporation Limited Ord Shares","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2539111402","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2539111402","pubTimestamp":1748471280,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"2226 GMT [Dow Jones]--Fisher & Paykel Healthcare gets a new bull in Jefferies following its FY 2025 result that showed growth across key divisions. Annual revenue rose by 16% on a year ago, with new app consumables up 20% and masks for treating sleep apnea up 14%. Gross margin expanded by 181 basis points. \"With lead share, ongoing gains through clinical practice, further operating leverage and, as we see it, better placed with regard to tariffs, we move to Buy ,\" says analyst Vanessa Thomson. Fisher & Paykel Healthcare is up 0.2% in early trading at NZ$35.07. ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"FPH.NZ":"Fisher & Paykel Healthcare Corporation Limited Ord Shares","HCSG":"Healthcare Svcs Group Inc","BK4097":"系统软件","PRGS":"Progress Software Corporation","BK8004":"医疗保健设备","LU2065732104.USD":"ALLSPRING (LUX) WF GLOBAL SMALL CAP EQUITY \"I\" (USD) ACC","BK4137":"综合支持服务"},"translate_title":"斐雪派克医疗保健的进展吸引了新的牛市讨论","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"PRGS":1,"HCSG":1,"FPH.NZ":1},"content_text":"2226 GMT [Dow Jones]--Fisher & Paykel Healthcare gets a new bull in Jefferies following its FY 2025 result that showed growth across key divisions. Annual revenue rose by 16% on a year ago, with new app consumables up 20% and masks for treating sleep apnea up 14%. Gross margin expanded by 181 basis points. \"With lead share, ongoing gains through clinical practice, further operating leverage and, as we see it, better placed with regard to tariffs, we move to Buy (from Hold),\" says analyst Vanessa Thomson. Fisher & Paykel Healthcare is up 0.2% in early trading at NZ$35.07. (david.winning@wsj.com) \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  May 28, 2025 18:28 ET (22:28 GMT)\n\n\n  Copyright (c) 2025 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"}}}